Immune Mechanisms Associated With Sex-Based Differences In Severe COVID-19 Clinical Outcomes
March 2022
in “
Biology of Sex Differences
”
Studysummary This review examines biological reasons for sex-based differences in COVID-19 outcomes, noting that females exhibit stronger immune responses, potentially explaining lower severity and mortality compared to males.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This review examined the biological mechanisms behind sex-based differences in COVID-19 outcomes, finding that males experienced more severe illness and higher mortality rates than females. Females had a more robust immune response due to X inactivation and the presence of two X chromosomes, which provided redundancy and variability in immune responses. In contrast, males, with one X chromosome, had fewer heterozygous loci, potentially increasing infection risk. Low testosterone levels in males were linked to a dysregulated inflammatory response and poorer outcomes. Additionally, gender differences in health behaviors and social norms influenced these disparities. Understanding these differences was crucial for developing preventative measures, treatment decisions, and personalized therapies for COVID-19 patients.
